s.karlsen_rph
TL3 Pharmacist · Oslo, NO
Pharmacist in an outpatient endocrine clinic. Mostly here for titration schedules and for the recurring argument about whether dose equivalence between incretin analogues means anything.
Joined 22 August 2024 · last posted 1d · groups: pharmacists, regional-na, trust-level-4
133 posts, newest first. Showing up to 150.
-
The most useful thing you learned here that was not the answer you came for Replied, post #62 · Lounge › Off topic · 27 Jul 2026 · 1 like That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
What a certificate commits its issuer to Replied, post #88 · Analytics › COA interpretation · 23 Jul 2026 · 26 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #117 · Compounds › Semaglutide · 23 Jul 2026 · 24 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #42 · Pharmacology › Receptor biology · 12 Jul 2026 · 21 likes This follows post #41 rather than contradicting it. The number people quote for receptor desensitisation is a central estimate presented without its interval, and the…
-
A site rotation scheme that is easy enough to actually follow Replied, post #111 · Practice › Administration · 10 Jul 2026 · 1 like The useful distinction on site rotation scheme is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #22 · Practice › Interactions · 8 Jul 2026 · 13 likes Reporting rather than recommending, on Antibiotics. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Does a peptide degrade silently, with no visual change? Replied, post #65 · Practice › Storage & stability · 7 Jul 2026 · 5 likes On post #61 — agreed on the reasoning, with one qualification. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein…
-
The headache that turns out to be dehydration — the long version Replied, post #61 · Nutrition & Training › Hydration & electrolytes · 4 Jul 2026 · 0 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures. The…
-
Sleep quality changes during weight loss Replied, post #6 · Wellbeing › Sleep · 30 Jun 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #38 · Analytics › Home & field testing · 29 Jun 2026 · 0 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Does a peptide degrade silently, with no visual change? Replied, post #58 · Practice › Storage & stability · 28 Jun 2026 · 0 likes On post #56 — agreed on the reasoning, with one qualification. Peptide: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #18 · Practice › Dosing & titration · 26 Jun 2026 · 8 likes Post #17 is the version of this I will quote in future. One addition. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #28 · Practice › Reconstitution · 24 Jun 2026 · 0 likes Post #24 describes the usual case. This is about the unusual one. Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it…
-
Insurance and replacement policies, compared Replied, post #39 · Sourcing › Logistics · 24 Jun 2026 · 2 likes The question underneath insurance and replacement policies is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #55 · Compounds › Tirzepatide · 23 Jun 2026 · 5 likes Picking up post #54: that is the part I would want checked first. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
-
Cold solution and stinging: the simplest fix Replied, post #36 · Practice › Administration · 16 Jun 2026 · 0 likes Marking my uncertainty on cold solution and stinging explicitly. I am confident about the direction, much less confident about the size, and not confident at all that…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #42 · Start Here › How to Ask · 14 Jun 2026 · 0 likes Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not a dose, a volume or a concentration until you say which.
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #5 · Lounge › Off topic · 10 Jun 2026 · 0 likes Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever. Caveat: everything above assumes the…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #9 · Nutrition & Training › Protein & intake · 8 Jun 2026 · 20 likes Post #8 answers the question as asked. The question underneath it is different. Eating anything at all: on substantial appetite suppression, eating enough total…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #50 · Wellbeing › Sleep · 3 Jun 2026 · 4 likes Noted, and thank you for writing it out rather than summarising it.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #4 · marked as the solution · Sourcing › Red flags · 2 Jun 2026 · 7 likes Pressure to pay outside a normal channel is the practical warning that has nothing to do with chemistry and is the one people ask about least. This is where my…
-
Constipation management, with a dietitian's contribution Replied, post #71 · Practice › Side effects · 28 May 2026 · 15 likes Distinguishing three things in the constipation management discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #73 · Sourcing › Vendor reports · 26 May 2026 · 6 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #4 · Pharmacology › Receptor biology · 25 May 2026 · 12 likes Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible explanation for differences between compounds in…
-
Step therapy requirements and how to satisfy them Replied, post #23 · Access › Insurance & coverage · 22 May 2026 · 7 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #43 · Outcomes › Progress reports · 10 May 2026 · 28 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding.
-
The best-written scientific paper you have read Replied, post #39 · Lounge › Off topic · 10 May 2026 · 11 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic. The…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #33 · Practice › Reconstitution · 1 May 2026 · 7 likes I read post #31 twice before replying, because I had assumed the opposite. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #122 · Pharmacology › Pharmacokinetics · 28 Apr 2026 · 7 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #32 · Sourcing › Red flags · 17 Apr 2026 · 33 likes That is consistent with mine, for whatever one more account is worth.
-
Search filters: what is missing Replied, post #47 · Meta › Site feedback · 16 Apr 2026 · 0 likes Two things can be true about search filters at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
-
[2026 update] What a purity-only report leaves out Replied, post #86 · Sourcing › Independent verification · 11 Apr 2026 · 5 likes Narrowing post #85, because the general version has more than one answer. The record shows what was measured. Everything beyond that is inference and this site tries to…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #56 · Outcomes › Body composition · 10 Apr 2026 · 2 likes Lean mass preservation has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
What a documentation review can and cannot tell you — a second dataset Replied, post #5 · Sourcing › Independent verification · 7 Apr 2026 · 2 likes Good question, well framed, and I would like to see it answered properly.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #68 · Research Methods › Statistics · 2 Apr 2026 · 25 likes On Measurement error in home scales: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #65 · Compounds › Tirzepatide · 31 Mar 2026 · 1 like I read post #61 twice before replying, because I had assumed the opposite. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that…
-
Constipation management, with a dietitian's contribution Replied, post #44 · Practice › Side effects · 24 Mar 2026 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #87 · Research Methods › N-of-1 designs · 21 Mar 2026 · 9 likes Narrowing post #86, because the general version has more than one answer. ABAB design is one of those subjects where the general answer and the answer for a specific…
-
The "under review" status pill and when a moderator applies it Replied, post #27 · Evidence › Preprints · 19 Mar 2026 · 5 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #43 · Access › International · 18 Mar 2026 · 5 likes Narrowing post #42, because the general version has more than one answer. Customs practice varies between entry points within the same country, which is why two people…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #39 · Practice › Administration · 17 Mar 2026 · 11 likes Injecting slowly is worth doing for volume rather than for chemistry. Larger volumes delivered quickly are the ones people report as uncomfortable. This is the sort of…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #55 · Research Methods › Statistics · 17 Mar 2026 · 0 likes On Measurement error in home scales I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #62 · Research Methods › N-of-1 designs · 13 Mar 2026 · 11 likes I had written a reply contradicting post #58 and deleted it. Here is what survived. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #16 · Sourcing › Logistics · 12 Mar 2026 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
-
Coming back to: Training through a dose escalation week Replied, post #50 · Nutrition & Training › Resistance training · 12 Mar 2026 · 0 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose. Happy to expand any of that if it is the useful…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #64 · Practice › Interactions · 11 Mar 2026 · 12 likes Answering the question post #62 raises rather than the one it answers. An honest declaration on Metformin co-administration: I have a prior here and it is strong enough…
-
Second pass at: Identical chromatograms across two different lots Replied, post #49 · Sourcing › Red flags · 7 Mar 2026 · 2 likes The arithmetic in post #47 is right; the assumption feeding it is the part to check. Identical chromatograms sits at the boundary between what this community can…
-
Contributing data without breaching anyone's privacy Replied, post #21 · Data & Tools › Datasets · 3 Mar 2026 · 8 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #3 · Practice › Dosing & titration · 2 Mar 2026 · 17 likes Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #128 · Access › International · 24 Feb 2026 · 5 likes An observation about Language barriers in accessing that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #32 · Analytics › Impurities & related substances · 24 Feb 2026 · 1 like Freeze-drying itself does not generate impurities in any significant way. Handling before and after it does, which is why transit conditions belong in the discussion.
-
About the COA interpretation category Replied, post #4 · Analytics › COA interpretation · 20 Feb 2026 · 2 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #129 · Sourcing › Independent verification · 19 Feb 2026 · 28 likes The version of interpreting a result that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds,…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #52 · Practice › Dosing & titration · 17 Feb 2026 · 32 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Personal import allowances, compared — a second dataset Replied, post #70 · Access › International · 17 Feb 2026 · 0 likes Import rules for personal quantities are jurisdiction-specific and change without much publicity. Establishing your own position is unavoidable.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #51 · Practice › Interactions · 16 Feb 2026 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #16 · Practice › Dosing & titration · 15 Feb 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Second pass at: What to keep a record of at the point of payment Replied, post #7 · Sourcing › Payments · 2 Feb 2026 · 15 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #69 · Pharmacology › Pharmacokinetics · 27 Jan 2026 · 17 likes Where I part company with post #68, and it is a narrow parting. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds,…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #89 · Compounds › Oral incretins · 20 Jan 2026 · 22 likes Answering the question post #86 raises rather than the one it answers. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #133 · Documentation › Doc review · 15 Jan 2026 · 0 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. It is worth stating the…
-
A partial dose because the pen emptied mid-injection Replied, post #80 · Practice › Administration · 10 Jan 2026 · 0 likes I had written a reply contradicting post #78 and deleted it. Here is what survived. The claim about partial dose because the pen upthread is stronger than its source…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #33 · Clinical › Bloodwork · 8 Jan 2026 · 1 like Post #30 is right about the mechanism and I think understates the practical bit. Glycaemic markers integrate over different periods. A point glucose and a longer-term…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #104 · Analytics › COA interpretation · 5 Jan 2026 · 5 likes A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing.
-
Measurement error in home scales, with a worked standard deviation — the long version Started this topic · Research Methods › Statistics · 19 Dec 2025 · 14 likes On the subject in the title: Measurement error in home scales, with a worked standard deviation — the long version Working notes rather than a conclusion. A narrow…
-
MHRA statements, read directly Replied, post #45 · Regional › UK & Ireland · 8 Dec 2025 · 18 likes Something worth flagging about MHRA statements: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #91 · Practice › Reconstitution · 6 Dec 2025 · 4 likes Picking up post #90: that is the part I would want checked first. The arithmetic on Over-dilution is the easy part and it is where the errors are, which is an…
-
Prescription requirements and telehealth models Replied, post #26 · Sourcing › Regulatory · 22 Nov 2025 · 0 likes Post #24 answers the question as asked. The question underneath it is different. Offering a way to settle prescription requirements and telehealth models rather than…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #128 · Start Here › How to Ask · 22 Nov 2025 · 4 likes Where I part company with post #124, and it is a narrow parting. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post,…
-
[2026 update] What steady state means for the decision to escalate Replied, post #64 · Practice › Dosing & titration · 11 Nov 2025 · 1 like Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #2 · Compounds › Tirzepatide · 5 Nov 2025 · 0 likes A methods point on tirzepatide titration schedules rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
-
Documentation that appears only after payment Replied, post #64 · Sourcing › Red flags · 1 Nov 2025 · 5 likes This follows post #61 rather than contradicting it. Where I have landed on documentation, having got it wrong once in public: the direction is clear, the magnitude is…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #7 · Access › Pricing · 29 Oct 2025 · 24 likes That is consistent with mine, for whatever one more account is worth.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #31 · Start Here › How to Ask · 27 Oct 2025 · 0 likes Taking post #28 at face value and following it one step further. Tag your own topic. Two accurate tags do more for how findable it is than a long title, and you can…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #39 · Practice › Interactions · 27 Oct 2025 · 0 likes I read the earlier replies on Warfarin and altered intake twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #32 · Analytics › Home & field testing · 16 Oct 2025 · 15 likes Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #76 · Compounds › Semaglutide · 16 Oct 2025 · 32 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #132 · Data & Tools › Calculators · 28 Sep 2025 · 5 likes On titration planner refuses, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #95 · Practice › Side effects · 26 Sep 2025 · 10 likes Two people in this thread mean different things by nausea timeline and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
Revisiting: German, French and Dutch differences, compared Replied, post #75 · Regional › European Union · 20 Sep 2025 · 13 likes I read post #71 twice before replying, because I had assumed the opposite. Practical note on German: write down what you expect before you look. The number of times I…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #74 · Practice › Side effects · 19 Sep 2025 · 2 likes Post #72 put the caveat in the right place and I want to underline it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #32 · Devices › Pens & autoinjectors · 25 Aug 2025 · 0 likes The instruction leaflet for a licensed pen is a genuinely good technical document and is almost never read past the first page. It answers most of what gets asked here.
-
What this community means by "a source", in practical terms Replied, post #82 · Start Here › Welcome · 23 Aug 2025 · 3 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
How to read a forest plot, properly, from scratch Replied, post #17 · Evidence › Trials · 19 Aug 2025 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #7 · Analytics › Method validation · 13 Aug 2025 · 18 likes Post #6 answers the question as asked. The question underneath it is different. Summarising the Robustness thread so far, since it is long and the answer is buried: the…
-
A request that was declined, and the reasoning — a second dataset Replied, post #42 · Documentation › Wiki requests · 10 Aug 2025 · 4 likes Post #39 is right about the mechanism and I think understates the practical bit. Format suggestions: if you think a maintained page could be clearer in its presentation…
-
Hepatic impairment and the absence of data Replied, post #9 · Clinical › Special populations · 9 Aug 2025 · 2 likes Post #7 describes the usual case. This is about the unusual one. Two people in this thread mean different things by hepatic impairment and are disagreeing about the…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #73 · Data & Tools › Calculators · 5 Aug 2025 · 0 likes Practical answer on titration planner refuses, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether…
-
Sodium, potassium and magnesium when intake drops Replied, post #52 · Nutrition & Training › Hydration & electrolytes · 10 Jul 2025 · 0 likes Sodium intake often falls sharply when processed food intake falls, and that transition is abrupt rather than gradual for many people.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #72 · Outcomes › Progress reports · 28 Jun 2025 · 7 likes Post #71 is the version of this I will quote in future. One addition. 18-month record is well covered in the tag pages, and the older discussions are better than the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #91 · Practice › Reconstitution · 14 Jun 2025 · 12 likes Everything in post #89 holds. The case it does not cover is the one I have. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #65 · Outcomes › Progress reports · 13 Jun 2025 · 0 likes Where the 18-month record discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Half-life, steady state, and accumulation worked through Replied, post #19 · Pharmacology › Pharmacokinetics · 24 May 2025 · 1 like Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather than efficacy. A loading dose would reach steady state faster and would…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #6 · Compounds › Retatrutide · 10 May 2025 · 5 likes Coming back to post #4, because the follow-up matters more than the original answer. Mass and identity: a report on retatrutide should state the mass detected by LC-MS,…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #98 · Devices › Cold chain · 6 May 2025 · 29 likes Where I would push back on the Domestic fridge temperature mapping consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Metformin co-administration and additive GI effects Replied, post #6 · Practice › Interactions · 20 Apr 2025 · 1 like The arithmetic in post #5 is right; the assumption feeding it is the part to check. A supplement is a drug for interaction purposes, and the fact that it is sold…
-
Relative retention time as a better inter-laboratory comparator Replied, post #3 · Analytics › Method validation · 20 Apr 2025 · 0 likes Picking up post #2: that is the part I would want checked first. Reporting a result to more decimal places than the method's precision supports is a small dishonesty…
-
Needle changes between doses on a reusable pen Replied, post #4 · Devices › Pens & autoinjectors · 18 Apr 2025 · 4 likes Post #2 and I disagree about the size of the effect, not about the direction. A pen that has been dropped may not be visibly damaged and may not deliver accurately…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #70 · Compounds › Semaglutide · 9 Apr 2025 · 32 likes Answering the question post #66 raises rather than the one it answers. SELECT: I have looked for the primary source twice and failed twice. Either it does not exist or…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #9 · Clinical › Comorbidities · 27 Mar 2025 · 5 likes Fair, and the limits you put on it are the part I will remember.
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #10 · Compounds › Repair & healing peptides · 26 Mar 2025 · 31 likes Worth separating two things that post #8 runs together. Whatever the answer on Oral versus injected administration claims turns out to be, the method for getting there…
-
Validating a method you did not develop — does this still hold? Replied, post #114 · Analytics › Method validation · 14 Mar 2025 · 20 likes That is the distinction I keep failing to hold on to. Written down now.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #54 · Sourcing › Regulatory · 2 Mar 2025 · 4 likes On post #50 — agreed on the reasoning, with one qualification. Import rules for personal quantities differ from commercial import rules and both differ by country.…
-
Consistent declarations and why they matter more than clever ones Replied, post #82 · Sourcing › Logistics · 24 Feb 2025 · 6 likes On consistent declarations, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Consistent declarations and why they matter more than clever ones Replied, post #63 · Sourcing › Logistics · 21 Feb 2025 · 30 likes I changed my mind about consistent declarations after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #54 · Devices › Cold chain · 18 Feb 2025 · 3 likes Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #42 · Analytics › Mass spectrometry · 30 Jan 2025 · 8 likes Building on post #39 rather than restating it. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #17 · Analytics › COA interpretation · 17 Jan 2025 · 0 likes Post #16 is the version of this I will quote in future. One addition. The distinction between release testing and characterisation is one industrial documents make and…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #22 · Practice › Reconstitution · 17 Jan 2025 · 0 likes Reconstituting a multi-strength kit is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles…
-
Recovery when intake is low: what to cut first Replied, post #83 · Nutrition & Training › Resistance training · 14 Jan 2025 · 8 likes Post #79 describes the usual case. This is about the unusual one. I would keep recovery and the decision it usually gets used for separate in this thread. They are…
-
Follow-up: Individual participant data versus aggregate data Replied, post #54 · Evidence › Meta-analyses · 10 Jan 2025 · 1 like Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Reading a supplementary appendix and finding the interesting part Replied, post #62 · Evidence › Trials · 8 Jan 2025 · 31 likes Adding the measurement that post #59 says would settle it. Worth stating the null on reading a supplementary appendix before we explain it: the observation may be…
-
How compounding permissions changed when supply normalised Replied, post #6 · Sourcing › Regulatory · 6 Jan 2025 · 5 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. That has been true for the cases…
-
Oxidation pathways for methionine and tryptophan Replied, post #24 · Analytics › Impurities & related substances · 27 Dec 2024 · 3 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Over-dilution: when your dose falls below one readable graduation Replied, post #10 · Practice › Reconstitution · 19 Dec 2024 · 0 likes Worth separating two things that post #8 runs together. Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very…
-
When "no data" is the complete and final answer Replied, post #40 · Compounds › Other compounds · 12 Dec 2024 · 6 likes Taking post #37 at face value and following it one step further. Storage guidance for the less common material is usually copied from the incretin guidance and may not…
-
[2026 update] New subcategory: rationale and scope Replied, post #46 · Meta › Announcements · 6 Dec 2024 · 14 likes New subcategory is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Fixed versus detachable needles: the trade-offs Replied, post #29 · Devices › Syringes & needles · 2 Dec 2024 · 0 likes This follows post #26 rather than contradicting it. Having read the whole fixed versus detachable needles thread before replying: the question in the first post has not…
-
EMA product information as a primary source — does this still hold? Replied, post #111 · Regional › European Union · 18 Nov 2024 · 5 likes Everything in post #107 holds. The case it does not cover is the one I have. The public assessment report published at authorisation is one of the best free technical…
-
Why "any advice?" is the least effective ending for a post Replied, post #19 · Start Here › How to Ask · 8 Nov 2024 · 0 likes Adding the measurement that post #16 says would settle it. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done…
-
When to suspect the method rather than the sample Replied, post #31 · Analytics › Method validation · 2 Nov 2024 · 0 likes I had written a reply contradicting post #27 and deleted it. Here is what survived. Stability-indicating method: one that can separate a compound from its degradation…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #18 · Compounds › Tirzepatide · 1 Nov 2024 · 7 likes Everything in post #16 holds. The case it does not cover is the one I have. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #43 · Compounds › Other compounds · 10 Oct 2024 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
The topic list is dense — is that deliberate? Replied, post #36 · Meta › Site feedback · 9 Oct 2024 · 3 likes Topic list has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #68 · Clinical › Prescriber conversations · 1 Oct 2024 · 1 like I had written a reply contradicting post #64 and deleted it. Here is what survived. Prescription logistics: confirm whether it will be filled locally, requires mail…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #59 · Evidence › Journal club · 30 Sep 2024 · 0 likes Post #55 put the caveat in the right place and I want to underline it. Sessions on negative or null results are consistently the most instructive and the hardest to get…
-
Why a preprint's supplementary material is often the best part Replied, post #31 · Evidence › Preprints · 20 Sep 2024 · 7 likes That is the distinction I keep failing to hold on to. Written down now.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #42 · Sourcing › Independent verification · 7 Sep 2024 · 1 like This is the answer, and the reason it is the answer is the more useful part.
-
About the Protein & intake category Replied, post #4 · Nutrition & Training › Protein & intake · 7 Sep 2024 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Telehealth prescribing models in the US Started this topic · Regional › North America · 26 Aug 2024 · 49 likes Telehealth prescribing models in the US Writing it up because I had to work it out twice and would rather nobody else did. Trying to work out what would count as…
-
Guidelines revision: what changed and why Replied, post #34 · Meta › Announcements · 25 Jul 2024 · 14 likes Coming back to post #30, because the follow-up matters more than the original answer. What would change my mind on guidelines revision is a second dataset collected by…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #37 · Practice › Dosing & titration · 2 Jul 2024 · 1 like The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Assessing a warm arrival: the decision process — one year on Replied, post #99 · Sourcing › Logistics · 1 Jun 2024 · 2 likes Post #98 answers the question as asked. The question underneath it is different. What I would check first on Assessing a warm arrival is whether the thing being…